We believe that TPE can have clinical benefits on severe COVID-19 when initiated promptly after early diagnosis based on rapid clinical deterioration and high inflammatory parameters, such as serum ferritin and high-sensitivity cardiac troponin I. We strongly recommend using TPE with convalescent plasma. The gene discussed is TNNI3; the disease is COVID-19.